Treatment with oral paricalcitol in daily clinical practice for patients with chronic kidney disease stage 3-4: a preliminary study

Author： Hadjiyannakos Dimitrios   Filiopoulos Vassilis   Trompouki Sofia   Sonikian Makroui   Karatzas Ioannis   Panagiotopoulos Konstantinos   Vlassopoulos Dimosthenis  

Publisher： Oxford University Press

ISSN： 2048-8505

Source： Clinical Kidney Journal, Vol.6, Iss.2, 2013-04, pp. : 164-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

T-type Ca Channel Blockers in Patients with Chronic Kidney Disease in Clinical Practice

By  

Current Hypertension Reviews, Vol. 9, Iss. 3, 2013-01 ,pp. : 202-209

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Kidney Disease

By Morgillo Teresa  

High Blood Pressure & Cardiovascular Prevention, Vol. 17, Iss. 2, 2010-06 ,pp. : 59-64

Adis International

Access to resources Recommend Favorite

Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update

By  

Current Cardiology Reviews, Vol. 9, Iss. 4, 2013-11 ,pp. : 331-339

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients

By de Oliveira Rodrigo Bueno   Liabeuf Sophie   Okazaki Hirokazu   Lenglet Aurelie   Desjardins Lucie   Lemke Horst-Dieter   Vanholder Raymond   Choukroun Gabriel   Massy Ziad A.  

Clinical Kidney Journal, Vol. 6, Iss. 1, 2013-02 ,pp. : 63-70

Oxford University Press

Access to resources Recommend Favorite

Vascular Calcification in Patients with Chronic Kidney Disease: Types, Clinical Impact and Pathogenesis

By  

Medical Principles and Practice, Vol. 20, Iss. 3, 2011-03 ,pp. : 203-212

Karger

Access to resources Recommend Favorite